# OnCo record nct05994131 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05994131/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05994131", "NCT05994131" ;
  schema:name "IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC"@en ;
  schema:description "A phase 1/2 trial of IN10018 and Furmonertinib in non-small-cell lung cancer, run by InxMed (Shanghai) Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05994131/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05994131> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-07-13" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/in10018/>, <https://onco.cc/drugs/furmonertinib/> ;
  onco:companies <https://onco.cc/companies/inxmed/> .